“…The most striking example of this was the elucidation of the '1p36 deletion syndrome' (Shapira et al, 1997;Knight-Jones et al, 2000). This was followed by clinically identifiable phenotypes being put forward for a number of other subtelomeric imbalances, for example, 1qter syndrome, 2q37.3 monosomy, 3q29 microdeletion syndrome, 5q35.3 subtelomeric deletion syndrome, 6q subtelomeric deletion syndrome, subtelomeric 9q microdeletion syndrome, 14q terminal deletion syndrome, 19p13.3-pter subtelomeric deletion syndrome and 22q deletion syndrome (de Vries et al, 2001a;van Karnebeek et al, 2002;Heilstedt et al, 2003;Rauch et al, 2003;Wilson et al, 2003;Aldred et al, 2004;Stevenson et al, 2004;Stewart et al, 2004;Archer et al, 2005;Eash et al, 2005; van Bever et Willatt et al, 2005). In most cases these studies were aided by the detailed phenotypic characterisation of a series of patients with similar regions of imbalance.…”